{"ref-id":"L14513","title":"Product monograph: Sandostatin (octreotide acetate) injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19667scm044_Sandostatin_lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L5473","title":"Australian Assessment Report","url":"https://www.tga.gov.au/sites/default/files/auspar-ranolazine-180220.pdf","parent_key":"BE0000925"}
{"ref-id":"L7342","title":"FDA Approved Drug Products: Geodon (ziprasidone HCl)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020825s059,020919s047lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L10544","title":"FDA label, topiramate","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020505s057_020844s048lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L5695","title":"PMC","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683610/","parent_key":"BE0000530"}
{"ref-id":"L6292","title":"Diltiazem Hydrochloride Injection Label - Bedford Laboratories","url":"https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Ben%20Venue_Bedford%20Labs/55390-565-10%20DLT%2050MG/5539056510","parent_key":"BE0000530"}
{"ref-id":"L6292","title":"Diltiazem Hydrochloride Injection Label - Bedford Laboratories","url":"https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Ben%20Venue_Bedford%20Labs/55390-565-10%20DLT%2050MG/5539056510","parent_key":"BE0000925"}
{"ref-id":"L7664","title":"Prozac FDA Label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7664","title":"Prozac FDA Label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L3513","title":"FDA Approved Drug Products: NORVIR (ritonavir) Capsules, Soft Gelatin for Oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020945s033lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L3513","title":"FDA Approved Drug Products: NORVIR (ritonavir) Capsules, Soft Gelatin for Oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020945s033lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L7243","title":"FDA Approved Drug Products: Duraclon Clonidine Hydrochloride Injection Solution","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020615s003lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L8657","title":"FDA Approved Drug Products: Provera Medroxyprogesterone Acetate Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011839s071lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L8660","title":"FDA Approved Drug Products: Conjugated Estrogens and Medroxyprogesterone Acetate Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020527s065lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L8663","title":"FDA Approved Drug Products: Medroxyprogesterone Acetate Subcutaneous Injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021583s023lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L8666","title":"FDA Approved Drug Products: Medroxyprogesterone Acetate Intramuscular Injection 150mg/mL","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020246s058lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L10478","title":"FDA Approved Drug Products: VerelanB. PM extended-release capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L10478","title":"FDA Approved Drug Products: VerelanB. PM extended-release capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L7958","title":"Furosemide - FDA Label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018667s036lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L10307","title":"FDA Approved Drug Products: Lo Loestrin Fe oral tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022501s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L12885","title":"FDA Approved Drug Products: Risperdal (risperidone) for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020272s085,020588s072,021444s058lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L12885","title":"FDA Approved Drug Products: Risperdal (risperidone) for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020272s085,020588s072,021444s058lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L8627","title":"FDA Approved Drugs: Oxcarbazepine","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021014s043lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L8630","title":"DPD Approved Drugs: Oxcarbazepine","url":"https://pdf.hres.ca/dpd_pm/00048247.PDF","parent_key":"BE0000530"}
{"ref-id":"L8633","title":"MedSafe NZ: Oxcarbazepine","url":"https://www.medsafe.govt.nz/profs/Datasheet/t/Trileptaltab.pdf","parent_key":"BE0000530"}
{"ref-id":"L11494","title":"FDA Approved Products: Estring (Estradiol vaginal ring)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020472s007lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L13802","title":"FDA Approved Drug Products: Lamprene (clofazimine) oral capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019500s014lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L4269","title":"Allegra (Fexofenadine Hydrochloride) FDA Label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020872s018,021963s002lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L10779","title":"DPD Approved Drugs: AllegraB. oral tablets","url":"https://pdf.hres.ca/dpd_pm/00053954.PDF","parent_key":"BE0000530"}
{"ref-id":"L4269","title":"Allegra (Fexofenadine Hydrochloride) FDA Label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020872s018,021963s002lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L10779","title":"DPD Approved Drugs: AllegraB. oral tablets","url":"https://pdf.hres.ca/dpd_pm/00053954.PDF","parent_key":"BE0004879"}
{"ref-id":"L11845","title":"FDA Approved Drug Products: Ortho Tri-Cyclen Norgestimate and Ethinyl Estradiol Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019653s058,019697s054lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L11848","title":"FDA Approved Drug Products: Ortho Tri-Cyclen Lo Norgestimate and Ethinyl Estradiol Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021241s027lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L10986","title":"FDA Approved Drug Products: PerforomistB. inhalation solution","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022007s015lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L11851","title":"Health Canada Product Monograph: Septra (sulfamethoxazole/trimethoprim) for intravenous injection","url":"https://pdf.hres.ca/dpd_pm/00043890.PDF","parent_key":"BE0000530"}
{"ref-id":"L7456","title":"FDA Approved Drug Products: Irbesartan Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020757s069lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7459","title":"FDA Approved Drug Products: Irbesartan and Hydrochlorothiazide Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020758s073lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7456","title":"FDA Approved Drug Products: Irbesartan Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020757s069lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L7459","title":"FDA Approved Drug Products: Irbesartan and Hydrochlorothiazide Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020758s073lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L11416","title":"FDA Approved Drug Products: Actos (pioglitazone) oral tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L4763","title":"FDA Approved Drug Products: Skelid Tiludronate Disodium Oral Tablets (Discontinued)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020707s006lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7889","title":"FDA Approved Drug Products: Carvedilol Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7892","title":"FDA Approved Drug Products: Carvedilol Oral Extended Release Capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L11638","title":"FDA Approved Drug Products: Levaquin (levofloxacin) oral tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020634s071lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L11629","title":"Health Canada Product Monograph: Clindamycin oral capsules","url":"https://pdf.hres.ca/dpd_pm/00054159.PDF","parent_key":"BE0000925"}
{"ref-id":"L8417","title":"Reglan injection FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L8138","title":"Colchicine FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022352s017lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L1162","title":"Empowerpharmacy","url":"https://www.empowerpharmacy.com/drugs/testosterone-propionate-injection.html","parent_key":"BE0000530"}
{"ref-id":"L7511","title":"FDA Approved Drug Products: Solifenacin Succinate Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021518s018lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L12063","title":"Health Canada Product Monograph: Kaletra (lopinavir/ritonavir) for oral use","url":"https://pdf.hres.ca/dpd_pm/00053305.PDF","parent_key":"BE0000925"}
{"ref-id":"L12063","title":"Health Canada Product Monograph: Kaletra (lopinavir/ritonavir) for oral use","url":"https://pdf.hres.ca/dpd_pm/00053305.PDF","parent_key":"BE0000530"}
{"ref-id":"L867","title":"Pharmaceuticals and Medical Devices Agency (PMDA): Topiroxostat review","url":"https://www.pmda.go.jp/files/000153624.pdf","parent_key":"BE0000530"}
{"ref-id":"L867","title":"Pharmaceuticals and Medical Devices Agency (PMDA): Topiroxostat review","url":"https://www.pmda.go.jp/files/000153624.pdf","parent_key":"BE0000925"}
{"ref-id":"L8684","title":"MULTAQB. (dronedarone hydrochloride) Product Monograph","url":"http://products.sanofi.ca/en/multaq.pdf","parent_key":"BE0000530"}
{"ref-id":"L7985","title":"FDA Approved Drug Products: Nebivolol Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021742s022lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L161","title":"Link","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515","parent_key":"BE0000925"}
{"ref-id":"L161","title":"Link","url":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2a87691-c9ad-4753-97a1-311fccfe6515","parent_key":"BE0000530"}
{"ref-id":"L10653","title":"FDA Approved Drug Products: Xcopri Cenobamate Oral Tablets","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L1186","title":"JCcardiol","url":"http://www.hellenicjcardiol.org/archive/full_text/2009/3/2009_3_199.pdf","parent_key":"BE0000530"}
{"ref-id":"L6814","title":"Symdeko FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L6814","title":"Symdeko FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L1143","title":"Tc-99m compounds","url":"http://eknygos.lsmuni.lt/springer/439/173-337.pdf","parent_key":"BE0000530"}
{"ref-id":"L1343","title":"Researchgate","url":"https://www.researchgate.net/publication/229817671_Aranidipine_MPC-1304_a_New_Dihydropyridine_Calcium_Antagonist_A_Review_of_Its_Antihypertensive_Action","parent_key":"BE0000530"}
{"ref-id":"L1343","title":"Researchgate","url":"https://www.researchgate.net/publication/229817671_Aranidipine_MPC-1304_a_New_Dihydropyridine_Calcium_Antagonist_A_Review_of_Its_Antihypertensive_Action","parent_key":"BE0000925"}
{"ref-id":"L1126","title":"Lacidipine Summary of Product Characteristics","url":"http://mri.cts-mrp.eu/download/NL_H_2992_002_FinalSPC.pdf","parent_key":"BE0000530"}
{"ref-id":"L1126","title":"Lacidipine Summary of Product Characteristics","url":"http://mri.cts-mrp.eu/download/NL_H_2992_002_FinalSPC.pdf","parent_key":"BE0000925"}
{"ref-id":"L2422","title":"COPPER(II) OXIDE - National Library of Medicine HSDB Database - Toxnet","url":"https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+266","parent_key":"BE0000530"}
{"ref-id":"L1407","title":"Deltyba, INN-Delamanid - European Medicines Agency - Europa EU","url":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002552/WC500166232.pdf","parent_key":"BE0000530"}
{"ref-id":"L1407","title":"Deltyba, INN-Delamanid - European Medicines Agency - Europa EU","url":"http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002552/WC500166232.pdf","parent_key":"BE0000925"}
{"ref-id":"L12405","title":"FDA Center for Drug Evaluation and Research: Pitolisant Non-clinical Review(s)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211150Orig1s000PharmR.pdf","parent_key":"BE0000530"}
{"ref-id":"L12405","title":"FDA Center for Drug Evaluation and Research: Pitolisant Non-clinical Review(s)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211150Orig1s000PharmR.pdf","parent_key":"BE0000925"}
{"ref-id":"L12852","title":"FDA Approved Drug Products: Koselugo (selumetinib) capsules for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L12852","title":"FDA Approved Drug Products: Koselugo (selumetinib) capsules for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L8225","title":"Pharmaceuticals and Medical Devices Agency Japan: Report on Istradefylline","url":"https://www.pmda.go.jp/files/000153870.pdf","parent_key":"BE0000530"}
{"ref-id":"L8225","title":"Pharmaceuticals and Medical Devices Agency Japan: Report on Istradefylline","url":"https://www.pmda.go.jp/files/000153870.pdf","parent_key":"BE0004879"}
{"ref-id":"L4834","title":"Clinical trials","url":"https://clinicaltrials.gov/ct2/show/NCT02181660","parent_key":"BE0000530"}
{"ref-id":"L12075","title":"Pharmaceuticals and Medical Devices Agency: Avigan (favipiravir) Review Report","url":"https://www.pmda.go.jp/files/000210319.pdf","parent_key":"BE0000530"}
{"ref-id":"L12075","title":"Pharmaceuticals and Medical Devices Agency: Avigan (favipiravir) Review Report","url":"https://www.pmda.go.jp/files/000210319.pdf","parent_key":"BE0004879"}
{"ref-id":"L14327","title":"FDA Approved Drug Products: Zepzelca (lurbinectedin) for intravenous injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213702s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L14327","title":"FDA Approved Drug Products: Zepzelca (lurbinectedin) for intravenous injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213702s000lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L10872","title":"FDA Approved Drug Products: NUBEQA (darolutamide) tablets, for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7883","title":"FDA Approved Drug Products: Turaliotm (pexidartinib) capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L7883","title":"FDA Approved Drug Products: Turaliotm (pexidartinib) capsules","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf","parent_key":"BE0000925"}
{"ref-id":"L8681","title":"Ozempic injection FDA label","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209637s001lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L13769","title":"FDA Approved Drug Products: QINLOCK (ripretinib) tablets, for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L13769","title":"FDA Approved Drug Products: QINLOCK (ripretinib) tablets, for oral use","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf","parent_key":"BE0004879"}
{"ref-id":"L12081","title":"FDA approved products: Extravia (interferon beta-1b) subcutaneous injection","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125290s067lbl.pdf","parent_key":"BE0000530"}
{"ref-id":"L9395","title":"FDA Approved Drug Products: Trikafta (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf","parent_key":"BE0000530"}